These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 23953057)
41. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
42. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells]. Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852 [TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness. Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962 [TBL] [Abstract][Full Text] [Related]
44. High risk HPV E6 oncoproteins impair the subcellular distribution of the four and a half LIM-only protein 2 (FHL2). Manzo-Merino J; Massimi P; Banks L; Lizano M Virology; 2015 Feb; 476():100-105. PubMed ID: 25540819 [TBL] [Abstract][Full Text] [Related]
45. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. Poljak-Blazi M; Jaganjac M; Sabol I; Mihaljevic B; Matovina M; Grce M Toxicol In Vitro; 2011 Feb; 25(1):160-6. PubMed ID: 21044880 [TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha. Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962 [TBL] [Abstract][Full Text] [Related]
47. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1. Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542 [TBL] [Abstract][Full Text] [Related]
48. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer. Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK Virol J; 2016 Apr; 13():60. PubMed ID: 27044426 [TBL] [Abstract][Full Text] [Related]
49. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350 [TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977 [TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Au Yeung CL; Tsang TY; Yau PL; Kwok TT Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Vogt M; Butz K; Dymalla S; Semzow J; Hoppe-Seyler F Oncogene; 2006 Jul; 25(29):4009-15. PubMed ID: 16462759 [TBL] [Abstract][Full Text] [Related]
53. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines]. Ryzhakova OS; Solov'eva NI Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343 [TBL] [Abstract][Full Text] [Related]
54. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Magaldi TG; Almstead LL; Bellone S; Prevatt EG; Santin AD; DiMaio D Virology; 2012 Jan; 422(1):114-24. PubMed ID: 22056390 [TBL] [Abstract][Full Text] [Related]
55. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis. Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489 [TBL] [Abstract][Full Text] [Related]
56. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637 [TBL] [Abstract][Full Text] [Related]
57. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Subbaramaiah K; Dannenberg AJ Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114 [TBL] [Abstract][Full Text] [Related]
58. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Lathion S; Schaper J; Beard P; Raj K Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182 [TBL] [Abstract][Full Text] [Related]
59. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [TBL] [Abstract][Full Text] [Related]
60. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients]. Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]